Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 50 out of 100. Genetics

Topic: Risk, prevention and care in population studies

Plain-language summary

In their study, Chen et al 1 examined the association between apolipoprotein E (APOE) genotype and longitudinal cognitive trajectories among middle-aged and older East Asian adults participating in the Healthy Aging Longitudinal Study of Taiwan (HALST).Although sporadic late-onset Alzheimer disease (AD) is polygenic, APOE remains the strongest genetic determinant of AD risk, with carriers of the APOE ε4 allele having increased odds of developing AD dementia in a dose-dependent manner compared with APOE ε3 homozygotes.Importantly, the magnitude of this association varies by genetic ancestry, with the strongest effects observed in East Asian populations, followed by European populations, and weaker associations in African and Amerindian populations.2 The HALST is a longitudinal study initially enrolling more than 5000 community-dwelling adults aged 55 years or older from 7 regions in Taiwan, encompassing rural and urban settings, multiple ethnic groups and dialects, and a wide range of socioeconomic backgrounds, including educational attainment and literacy.3 Participants completed in-home interviews and hospital-based visits that included physical and cognitive assessments and collection of blood and urine samples every 5 years, with annual telephone follow-up assessments of health status.The first study wave occurred between 2009 and 2013, and the second wave between 2014 and 2019.3 In the study by Chen et al, 1 cognitive trajectories were assessed using repeated Mini-Mental State Examination (MMSE) scores, with a generous baseline cutoff score of 16 or higher to define unimpaired cognitive status, reflecting the cohort's low mean educational attainment and high prevalence of illiteracy.The authors also performed genome-wide genotyping to examine associations between MMSE trajectories and a polygenic risk score (PRS) excluding APOE.Of the 5664 participants who completed the first study wave, 4392 with genetic data and baseline MMSE scores of 16 or greater were the focus of the present study 1 and had the following APOE genotype distribution: 17.3% were APOE ε4 carriers (15.2% with ε3/ε4, 1.3% with ε2/ε4, and 0.8% with ε4/ε4), 70.2% were APOE ε3 homozygotes, and 12.6% carried the generally protective APOE ε2 allele (ie, 12.0% APOE ε2/ε3 and 0.6% APOE ε2/ε2 carriers; APOE ε2/ε4 carriers were excluded from APOE ε2 analyses).Of these 4392 participants, 3259 completed the second study wave and had longitudinal MMSE scores.Over a mean follow-up of 6.3 years, APO

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 21 participants. This commentary discusses a study of APOE genotype and longitudinal cognitive trajectories among middle-aged and older East Asian adults in Taiwan. Reported effect size: 17.3%; 15.2%; 1.3%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Qian, J., & Serrano‐Pozo, A. (2026). APOE ε4 and Cognition Among Middle-Aged and Older East Asian Adults. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.0860

Vancouver

Qian J, Serrano‐Pozo A. APOE ε4 and Cognition Among Middle-Aged and Older East Asian Adults. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.0860. PMID: 41790473.

BibTeX

@article{qian2026-41790473,
  author  = {Qian, Jing and Serrano‐Pozo, Alberto},
  title   = {{APOE ε4 and Cognition Among Middle-Aged and Older East Asian Adults}},
  journal = {JAMA Network Open},
  year    = {2026},
  doi     = {10.1001/jamanetworkopen.2026.0860},
  pmid    = {41790473},
  url     = {https://doi.org/10.1001/jamanetworkopen.2026.0860}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This commentary discusses a study of APOE genotype and longitudinal cognitive trajectories among middle-aged and older East Asian adults in Taiwan. It notes that APOE ε4 carriers have increased odds of developing Alzheimer dementia in a dose-dependent manner, and that the strength of this association varies by genetic ancestry.

Study details

How this study scored 50/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 50 of 100.50 of 100 points earned50 not earned

Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (JAMA Network Open)
Journal's citation record 2 / 4 JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 21 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Alberto Serrano‐Pozo: h-index 46 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Massachusetts Amherst: institution h-index 913 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41790473)
Free to read 2 / 2 Free to read
Total 50 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Genetics from nearby years

Also tagged “diet”

1,116 studies in the library carry the topic tag “diet”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,116 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Genetics

See all studies in Genetics →